CMMB
Price
$1.24
Change
-$0.04 (-3.12%)
Updated
Apr 30, 12:40 PM (EDT)
Capitalization
25.27M
8 days until earnings call
ORKA
Price
$10.22
Change
-$0.22 (-2.11%)
Updated
Apr 30, 01:00 PM (EDT)
Capitalization
384.89M
Ad is loading...

CMMB vs ORKA

Header iconCMMB vs ORKA Comparison
Open Charts CMMB vs ORKABanner chart's image
Chemomab Therapeutics
Price$1.24
Change-$0.04 (-3.12%)
Volume$100
Capitalization25.27M
Oruka Therapeutics
Price$10.22
Change-$0.22 (-2.11%)
Volume$100
Capitalization384.89M
CMMB vs ORKA Comparison Chart
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMMB vs. ORKA commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Buy and ORKA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (CMMB: $1.28 vs. ORKA: $10.45)
Brand notoriety: CMMB and ORKA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 66% vs. ORKA: 57%
Market capitalization -- CMMB: $25.27M vs. ORKA: $384.89M
CMMB [@Biotechnology] is valued at $25.27M. ORKA’s [@Biotechnology] market capitalization is $384.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileORKA’s FA Score has 1 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • ORKA’s FA Score: 1 green, 4 red.
According to our system of comparison, CMMB is a better buy in the long-term than ORKA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 5 TA indicator(s) are bullish while ORKA’s TA Score has 5 bullish TA indicator(s).

  • CMMB’s TA Score: 5 bullish, 5 bearish.
  • ORKA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ORKA is a better buy in the short-term than CMMB.

Price Growth

CMMB (@Biotechnology) experienced а +9.40% price change this week, while ORKA (@Biotechnology) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.55%. For the same industry, the average monthly price growth was +2.15%, and the average quarterly price growth was -10.01%.

Reported Earning Dates

CMMB is expected to report earnings on Aug 08, 2025.

ORKA is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+1.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORKA($385M) has a higher market cap than CMMB($25.3M). CMMB YTD gains are higher at: -29.282 vs. ORKA (-46.106). ORKA has more cash in the bank: 411M vs. CMMB (19.4M). CMMB has less debt than ORKA: CMMB (342K) vs ORKA (988K).
CMMBORKACMMB / ORKA
Capitalization25.3M385M7%
EBITDA-15.37MN/A-
Gain YTD-29.282-46.10664%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash19.4M411M5%
Total Debt342K988K35%
FUNDAMENTALS RATINGS
CMMB vs ORKA: Fundamental Ratings
CMMB
ORKA
OUTLOOK RATING
1..100
915
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
4251
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORKA's Valuation (5) in the null industry is in the same range as CMMB (31) in the Biotechnology industry. This means that ORKA’s stock grew similarly to CMMB’s over the last 12 months.

CMMB's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as ORKA (100) in the null industry. This means that CMMB’s stock grew similarly to ORKA’s over the last 12 months.

CMMB's SMR Rating (95) in the Biotechnology industry is in the same range as ORKA (100) in the null industry. This means that CMMB’s stock grew similarly to ORKA’s over the last 12 months.

CMMB's Price Growth Rating (42) in the Biotechnology industry is in the same range as ORKA (51) in the null industry. This means that CMMB’s stock grew similarly to ORKA’s over the last 12 months.

CMMB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ORKA (100) in the null industry. This means that CMMB’s stock grew similarly to ORKA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMMBORKA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
84%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKAX81.66N/A
N/A
Rydex Banking H
ACLAX15.10N/A
N/A
American Century Mid Cap Value A
TADFX7.69N/A
N/A
Transamerica Sustainable Equity Inc R6
ARREX25.95N/A
N/A
American Century Real Estate R5
GMNPX39.22N/A
N/A
Goldman Sachs MLP Energy Infras P

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
-4.48%
AXON - CMMB
37%
Loosely correlated
+1.44%
SPRB - CMMB
36%
Loosely correlated
+5.47%
OVID - CMMB
33%
Poorly correlated
-3.34%
SYRE - CMMB
32%
Poorly correlated
+2.39%
DSGN - CMMB
30%
Poorly correlated
+8.13%
More

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with PCVX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
+1.65%
PCVX - ORKA
44%
Loosely correlated
+5.68%
RLFTF - ORKA
31%
Poorly correlated
+5.56%
ENTX - ORKA
28%
Poorly correlated
-2.19%
RLFTY - ORKA
24%
Poorly correlated
-7.69%
CMMB - ORKA
22%
Poorly correlated
-4.48%
More